UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000034044 |
|---|---|
| Receipt number | R000038421 |
| Scientific Title | A Prospective, Multicenter, Study to Evaluate the Safety and Effectiveness of the JOURNEY II XR Total Knee System with VERILAST Technology |
| Date of disclosure of the study information | 2018/11/01 |
| Last modified on | 2024/03/30 09:01:22 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/09/05 19:52:44 | ||
| 2 | Update | 2019/01/08 19:08:48 | Recruitment status |
|
| 3 | Update | 2019/01/15 10:52:44 | UMIN ID2 |
|
| 4 | Update | 2019/01/15 13:44:58 | Last name of lead principal investigator Last name of lead principal investigator Organization Organization Address Address TEL Organization1 Address1 Tel1 Email1 |
|
| 5 | Update | 2019/01/16 11:27:11 | Research ethics review Email1 |
|
| 6 | Update | 2019/03/06 10:24:41 | Last name of contact person Last name of contact person Name of person sending information Name of person sending information |
|
| 7 | Update | 2019/03/06 10:29:07 | Anticipated trial start date |
|
| 8 | Update | 2019/03/06 16:36:06 | UMIN ID3 |
|
| 9 | Update | 2019/10/01 14:24:41 | Date of IRB Last follow-up date |
|
| 10 | Update | 2021/03/07 23:00:22 | Target sample size |
|
| 11 | Update | 2021/03/07 23:07:17 | Recruitment status |
|
| 12 | Update | 2021/04/13 16:55:50 | UMIN ID1 UMIN ID3 |
|
| 13 | Update | 2021/04/13 16:57:21 | UMIN ID1 UMIN ID2 |
|
| 14 | Update | 2021/07/08 11:48:52 | UMIN ID3 |
|
| 15 | Update | 2022/10/21 14:24:07 | UMIN ID2 |
|
| 16 | Update | 2022/10/24 11:06:09 | UMIN ID2 |
|
| 17 | Update | 2022/10/24 11:09:50 | UMIN ID1 |
|
| 18 | Update | 2023/09/21 16:59:29 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Division name Zip code Address Address TEL Name of person sending information Name of person sending information Division name Address Address TEL Organization Organization Address Address Tel |
|
| 19 | Update | 2023/09/21 17:11:52 | Number of participants that the trial has enrolled Results Delayed Results Delay Reason Results Delay Reason |
|
| 20 | Update | 2024/03/01 10:22:28 | Key inclusion criteria |
|
| 21 | Update | 2024/03/01 11:00:07 | Last name of contact person Last name of contact person Name of person sending information Name of person sending information |
|
| 22 | Update | 2024/03/01 11:04:44 | Anticipated trial start date Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 23 | Update | 2024/03/30 09:01:23 | Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures IPD sharing Plan description IPD sharing Plan description |
